• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三叶苦(Orthosiphon)对比安慰剂治疗多发性慢性疾病合并肾结石:一项随机对照试验。

Orthosiphon versus placebo in nephrolithiasis with multiple chronic complaints: a randomized control trial.

机构信息

Department of Community Medicine, Department of Community Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.

出版信息

Evid Based Complement Alternat Med. 2009 Dec;6(4):495-501. doi: 10.1093/ecam/nem141. Epub 2007 Oct 25.

DOI:10.1093/ecam/nem141
PMID:18955258
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2781771/
Abstract

Nephrolithiasis in the communities of Northeast Thailand frequently presents with multiple chronic health complaints, i.e. myofascial pain, back pain, dyspepsia, arthralgia, headache, fatigue, frank paresthesia, dysuria and any of these aggravated by purine-rich food (PRF). We assessed the efficacy of Orthosiphon in treating subjects with at least two active symptoms and negative for urine white blood cells. Subjects were randomly allocated to two groups. Crude extract of Orthosiphon given in a capsule (equivalent to 1.6-1.8 g of dried leaves of Orthosiphon) two times a day to Group 1 (n = 36) and a placebo to Group 2 (n = 40) for 14 days. The medication for each subject was packed and its code kept secret until the data analysis. Both groups were asked not to consume any of 25 purine-rich foods (PRFs) during treatment. The primary measure was the reduced sum of active severity symptoms as recorded using the visual analog scale before and after therapy (i.e. on day 7 and 14). The data on 76 subjects were processed. The mean of the total scores (95% CI) of the symptoms in each group were decreased significantly (P < 0.001); 185.6 (153.3, 218.0) to 94.7 (58.2, 131.2) in the Orthosiphon group and 196.1 (164.4, 227.8) to 89.6 (62.8, 116.5) in the placebo group. When comparing between groups, no statistically significant difference was found. The mean consumption in PRFs was significantly decreased (P < 0.001) in both groups; however, Orthosiphon did not have additional benefit over placebo at 7 and 14 days of treatment during which they reduced these foods.

摘要

泰国东北部社区的肾结石患者常伴有多种慢性健康问题,如肌筋膜疼痛、背痛、消化不良、关节痛、头痛、疲劳、感觉异常、排尿困难以及任何因富含嘌呤的食物(PRF)而加重的症状。我们评估了三叶苦对至少有两种活跃症状且尿液白细胞阴性的患者的治疗效果。将患者随机分为两组。一组给予三叶苦粗提取物胶囊(相当于 1.6-1.8 克三叶苦干叶),每日两次(n=36);另一组给予安慰剂(n=40),疗程为 14 天。每位患者的药物均包装并保密,直到数据分析。两组患者在治疗期间均被要求不食用 25 种富含嘌呤的食物(PRF)。主要观察指标是治疗前后(即第 7 天和第 14 天)使用视觉模拟量表记录的活跃严重症状总和的减少。对 76 例患者的数据进行了处理。每组症状的总分平均值(95%CI)均显著降低(P<0.001):三叶苦组从 185.6(153.3,218.0)降至 94.7(58.2,131.2),安慰剂组从 196.1(164.4,227.8)降至 89.6(62.8,116.5)。组间比较差异无统计学意义。两组 PRF 的平均摄入量均显著降低(P<0.001);然而,在治疗的第 7 和第 14 天,与安慰剂相比,三叶苦并没有额外的获益,且患者在这两个时间点都减少了这些食物的摄入。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02e6/2781771/0b5337d06664/nem141f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02e6/2781771/74af381166e6/nem141f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02e6/2781771/0b5337d06664/nem141f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02e6/2781771/74af381166e6/nem141f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02e6/2781771/0b5337d06664/nem141f2.jpg

相似文献

1
Orthosiphon versus placebo in nephrolithiasis with multiple chronic complaints: a randomized control trial.三叶苦(Orthosiphon)对比安慰剂治疗多发性慢性疾病合并肾结石:一项随机对照试验。
Evid Based Complement Alternat Med. 2009 Dec;6(4):495-501. doi: 10.1093/ecam/nem141. Epub 2007 Oct 25.
2
Risks of repeated visits for uninvestigated dyspepsia in three community hospitals of Khon Kaen, Thailand.
J Med Assoc Thai. 2010 Mar;93 Suppl 3:S30-7.
3
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
4
Diet, fluid, or supplements for secondary prevention of nephrolithiasis: a systematic review and meta-analysis of randomized trials.饮食、液体或补充剂用于肾结石的二级预防:系统评价和随机试验荟萃分析。
Eur Urol. 2009 Jul;56(1):72-80. doi: 10.1016/j.eururo.2009.03.031. Epub 2009 Mar 13.
5
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
6
A randomized, double-blind, placebo-controlled, multicenter, repeat-dose study of two intravenous acetaminophen dosing regimens for the treatment of pain after abdominal laparoscopic surgery.一项随机、双盲、安慰剂对照、多中心、重复剂量研究,评估两种静脉用对乙酰氨基酚给药方案治疗腹腔镜腹部手术后疼痛的效果。
Clin Ther. 2010 Dec;32(14):2348-69. doi: 10.1016/j.clinthera.2010.12.011.
7
Prophylactic effects of Orthosiphon stamineus Benth. extracts on experimental induction of calcium oxalate nephrolithiasis in rats.金钱草提取物对大鼠实验性草酸钙肾结石形成的预防作用。
J Ethnopharmacol. 2012 Dec 18;144(3):761-7. doi: 10.1016/j.jep.2012.09.052. Epub 2012 Oct 30.
8
Urinary metabonomics elucidate the therapeutic mechanism of Orthosiphon stamineus in mouse crystal-induced kidney injury.尿代谢组学阐明了越南参在小鼠晶体诱导肾损伤中的治疗机制。
J Ethnopharmacol. 2015 May 26;166:323-32. doi: 10.1016/j.jep.2015.03.025. Epub 2015 Mar 17.
9
A long-term study on the efficacy of a herbal plant, Orthosiphon grandiflorus, and sodium potassium citrate in renal calculi treatment.一项关于草本植物大花鸡骨草和柠檬酸钾治疗肾结石疗效的长期研究。
Southeast Asian J Trop Med Public Health. 2001 Sep;32(3):654-60.
10
A randomized, double-blind, placebo-controlled trial of onabotulinumtoxin A trigger point injections for myofascial pelvic pain.一项肌筋膜性骨盆疼痛的肉毒毒素 A 触发点注射的随机、双盲、安慰剂对照试验。
Am J Obstet Gynecol. 2019 Nov;221(5):517.e1-517.e9. doi: 10.1016/j.ajog.2019.06.044. Epub 2019 Jun 27.

引用本文的文献

1
Comparison of Herbal and Potassium Nitrate Toothpastes in Managing Dentin Hypersensitivity: A Randomized Controlled Trial.草药牙膏与硝酸钾牙膏治疗牙本质敏感症的比较:一项随机对照试验
Dent J (Basel). 2025 Aug 15;13(8):369. doi: 10.3390/dj13080369.
2
Treatment of Urolithiasis with Medicinal Plant : A Nationwide Cohort Study.药用植物治疗尿路结石:一项全国性队列研究。
Evid Based Complement Alternat Med. 2018 Apr 11;2018:8403648. doi: 10.1155/2018/8403648. eCollection 2018.
3
Effect of Flos carthami Extract and α 1-Adrenergic Antagonists on the Porcine Proximal Ureteral Peristalsis.

本文引用的文献

1
Antimicrobial Activity of Indigofera suffruticosa.菘蓝的抗菌活性。
Evid Based Complement Alternat Med. 2006 Jun;3(2):261-5. doi: 10.1093/ecam/nel010. Epub 2006 Apr 5.
2
Traditional and Modern Biomedical Prospecting: Part II-the Benefits: Approaches for a Sustainable Exploitation of Biodiversity (Secondary Metabolites and Biomaterials from Sponges).传统与现代生物医学探索:第二部分——益处:生物多样性可持续开发的方法(海绵体的次生代谢产物和生物材料)
Evid Based Complement Alternat Med. 2004 Sep 1;1(2):133-144. doi: 10.1093/ecam/neh030.
3
A long-term study on the efficacy of a herbal plant, Orthosiphon grandiflorus, and sodium potassium citrate in renal calculi treatment.
红花提取物和α1-肾上腺素能拮抗剂对猪近端输尿管蠕动的影响。
Evid Based Complement Alternat Med. 2014;2014:437803. doi: 10.1155/2014/437803. Epub 2014 Jul 9.
4
An emerging translational model to screen potential medicinal plants for nephrolithiasis, an independent risk factor for chronic kidney disease.一种新兴的转化模型,用于筛选潜在的治疗肾结石的药用植物,肾结石是慢性肾脏病的一个独立危险因素。
Evid Based Complement Alternat Med. 2014;2014:972958. doi: 10.1155/2014/972958. Epub 2014 Jul 6.
一项关于草本植物大花鸡骨草和柠檬酸钾治疗肾结石疗效的长期研究。
Southeast Asian J Trop Med Public Health. 2001 Sep;32(3):654-60.
4
Incidence of urolithiasis in northeast Thailand.
Int J Urol. 1997 Nov;4(6):537-40. doi: 10.1111/j.1442-2042.1997.tb00304.x.
5
[Antifungal activity of plant extracts used therapeutically. II. Study of 40 extracts on 9 fungal strains].[治疗用植物提取物的抗真菌活性。II. 40种提取物对9种真菌菌株的研究]
Ann Pharm Fr. 1985;43(1):77-81.
6
Screening of Taiwanese crude drugs for antibacterial activity against Streptococcus mutans.台湾生药对变形链球菌抗菌活性的筛选。
J Ethnopharmacol. 1989 Dec;27(3):285-95. doi: 10.1016/0378-8741(89)90003-2.
7
Blood and urinary aggregator and inhibitor composition in controls and renal-stone patients from northeastern Thailand.
Nephron. 1991;59(4):591-6. doi: 10.1159/000186649.
8
Effects of Folia orthosiphonis on urinary stone promoters and inhibitors.猫须草对尿路结石促进剂和抑制剂的影响。
J Med Assoc Thai. 1991 Jun;74(6):318-21.
9
Prevalence of upper urinary tract stone disease in a rural community of north-eastern Thailand.
Br J Urol. 1992 Mar;69(3):240-4. doi: 10.1111/j.1464-410x.1992.tb15520.x.